Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PDS may need financing?

"During the period June 1, 2010 through August 6, 2010, we purchased 348,400 shares of our common stock at an aggregate cost of $38,755 pursuant to our stock buyback program."

That is 348,000 shares that can't be voted on to oust the board. Instead of loaning the million dollars they could have bought 9 million shares plus. Now that would have been a better investment IMO.

Share
New Message
Please login to post a reply